Your browser doesn't support javascript.
loading
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease.
Jain, Amy Patel; Gellada, Norman; Ugradar, Shoaib; Kumar, Ada; Kahaly, George; Douglas, Raymond.
Affiliation
  • Jain AP; Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California, USA amypatel09@gmail.com.
  • Gellada N; Radiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Ugradar S; Orbital and Ophthalmic Plastic Surgery, Jules Stein Eye Institute, Los Angeles, California, USA.
  • Kumar A; Horizon Therapeutics, Chicago, Illinois, USA.
  • Kahaly G; Universitat Mainz, Mainz, Germany.
  • Douglas R; Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Br J Ophthalmol ; 106(2): 165-171, 2022 02.
Article in En | MEDLINE | ID: mdl-33172865
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orbit / Graves Ophthalmopathy Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Ophthalmol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orbit / Graves Ophthalmopathy Type of study: Clinical_trials Limits: Humans Language: En Journal: Br J Ophthalmol Year: 2022 Document type: Article Affiliation country: Country of publication: